Protein inhibitor shown as potential treatment approach for common mutations found in non-Hodgkin lymphomas
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations A study at The…
Browsing: CREBBP
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations A study at The…